Aligos Therapeutics Inc (ALGS)
19.46
+0.01
(+0.05%)
USD |
NASDAQ |
Nov 14, 16:00
19.40
-0.06
(-0.31%)
After-Hours: 20:00
Aligos Therapeutics Total Assets (Quarterly): 88.43M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.43M |
| June 30, 2024 | 108.81M |
| March 31, 2024 | 127.90M |
| December 31, 2023 | 151.53M |
| September 30, 2023 | 85.85M |
| June 30, 2023 | 106.13M |
| March 31, 2023 | 121.74M |
| December 31, 2022 | 146.69M |
| September 30, 2022 | 164.07M |
| June 30, 2022 | 182.52M |
| Date | Value |
|---|---|
| March 31, 2022 | 210.47M |
| December 31, 2021 | 235.37M |
| September 30, 2021 | 263.07M |
| June 30, 2021 | 211.88M |
| March 31, 2021 | 234.54M |
| December 31, 2020 | 265.30M |
| September 30, 2020 | 92.18M |
| June 30, 2020 | 148.68M |
| December 31, 2019 | 146.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.85M
Minimum
Sep 2023
265.30M
Maximum
Dec 2020
162.72M
Average
148.68M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Haemonetics Corp | 2.525B |
| Pliant Therapeutics Inc | 445.66M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.33M |
| Shareholders Equity (Quarterly) | 50.10M |
| Current Ratio | 3.809 |